The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A mechanistic radiographic and biologic phase 2 study of sunitinib in relapsed/refractory esophageal (E) and gastroesophageal (GE) cancers.
Christina Sing-Ying Wu
No relevant relationships to disclose
Sameh Mikhail
No relevant relationships to disclose
Lai Wei
No relevant relationships to disclose
Ludmila Katherine Martin
No relevant relationships to disclose
Xiaobai Li
No relevant relationships to disclose
Cynthia Dawn Timmers
No relevant relationships to disclose
James Lin Chen
No relevant relationships to disclose
Sanaa Tahiri
No relevant relationships to disclose
Alison Neal
No relevant relationships to disclose
Jon P Walker
No relevant relationships to disclose
Samer S El-Dika
No relevant relationships to disclose
Jonathan B Rock
No relevant relationships to disclose
Daniel Clark
No relevant relationships to disclose
Xiangyu Yang
No relevant relationships to disclose
Kevin Foy
No relevant relationships to disclose
James Jingyao Liu
No relevant relationships to disclose
Michael V. Knopp
No relevant relationships to disclose
Pravin Kaumaya
No relevant relationships to disclose
Tanios B. Bekaii-Saab
Research Funding - Pfizer